ClinicalTrials.Veeva

Menu

Antibiotic Duration in Post-appendectomy Abscess

Phoenix Children's Hospital logo

Phoenix Children's Hospital

Status and phase

Terminated
Phase 4

Conditions

Perforated Appendicitis
Complicated Appendicitis

Treatments

Drug: ampicillin/clavulanate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a randomized study of patients 2-17 years old who are diagnosed with perforated appendicitis and develop an abscess after laparoscopy that is subsequently drained. Patients will be randomized to either receive an 8-day or a 4-day course of antibiotics. The aim of this study is to determine whether duration of antibiotic treatment at discharge demonstrates significant differences in clinical outcomes.

Full description

The central aim of this study is to determine whether duration of antibiotic treatment at discharge demonstrates significant differences in primary and secondary clinical outcomes. Specifically, this research aims to determine whether the readmission rate and length of stay for pediatric patients diagnosed with perforated appendicitis who form a post-laparoscopic abscess that is treated with percutaneous drainage and are treated with a 8-day oral antibiotic regimen at discharge is significantly different from those treated with a fixed 4-day regimen at discharge.

This study includes patients ages 2-17 years old who present with perforated appendicitis-as diagnosed at laparoscopy and photographed as either a hole or as feces in the abdomen-and who develop an abscess after laparoscopy that is treated with percutaneous drainage.

All post-laparoscopic abscess patients will receive the standard of care for antibiotic therapy at Phoenix Children's Hospital-IV ceftriaxone/metronidazole-until afebrile and tolerating food. All patients will be treated with the PCH standard of care and receive in-patient treatment for abscess until afebrile.

At discharge, study patients will be randomly assigned to either an 8-day ampicillin/clavulanate regimen or a 4-day ampicillin/clavulanate regimen. Pediatric patients who are allergic to ampicillin will be excluded from the study. Patients will be followed thirty days post discharge to assess clinical outcomes.

Enrollment

7 patients

Sex

All

Ages

2 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 2 to 17 years of age
  • Diagnosis of perforated appendicitis at laparoscopy
  • Development of a post-appendectomy abscess that is treated with percutaneous drainage.

Exclusion criteria

  • Patients who are allergic to ampicillin

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

7 participants in 2 patient groups

8-day
Other group
Description:
8-day course of ampicillin clavulanate antibiotic
Treatment:
Drug: ampicillin/clavulanate
4-day
Other group
Description:
4--day course of ampicillin clavulanate antibiotic
Treatment:
Drug: ampicillin/clavulanate

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems